JX11502MA / Zhejiang Jingxin Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JX11502MA / Zhejiang Jingxin Pharma
NCT05233657: A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

Recruiting
1
58
RoW
JX11502MA, Placebo
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Schizophrenia
01/22
02/22

Download Options